Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price Hits Fresh 52-Week High After 7.78% Jump

Ipca Laboratories Ltd. rose to Rs 1,868.60, up 7.78% today, after hitting a fresh 52-week high of Rs 1,945.00. Market capitalisation stood at Rs 43,983.43 crore.

Ipca Laboratories Share Price was at Rs 1,868.60 on 17 August 2026, up Rs 134.95 or 7.78% from the previous close of Rs 1,733.65, after the stock touched a fresh 52-week high of Rs 1,945.00. The company’s market capitalisation stood at Rs 43,983.43 crore, placing it firmly among closely watched names in the Healthcare pack.

For investors tracking Ipca Laboratories Share Price Today, the move matters because it combines a sharp single-session gain with a new one-year high and Rs 30.70 crore in turnover. The supplied data confirms the price event and shows unusually strong intraday expansion from the opening level, although it does not establish a company-specific catalyst behind the rally.

That is why Ipca Laboratories Stock News is drawing attention in Stock Market Today searches. A fresh 52-week peak often brings a company into the list of Stocks in News, Top Gainers Today and 52 Week High Stocks. Univest notes that the current move stands out not only for the percentage rise, but also for the gap between the previous close, opening price and intraday high. Investors now have a clear price event to monitor, along with valuation context, sector positioning and peer comparison.

Ipca Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,868.6
Previous Close	Rs 1,733.65
Today's Change	+Rs 134.95 (+7.78%)
Day Open	Rs 1,800.35
Fresh 52-Week High	Rs 1,945
Day Low	Rs 1,800.35
Current Volume	1,64,298
Turnover	Rs 30.7 crore
Market Capitalisation	Rs 43,983.43 crore

Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,868.6. versus the previous close of Rs 1,733.65, a rise of 7.78%. The stock opened at Rs 1,800.35, reached Rs 1,945, touched Rs 1,800.35. Reported volume was 1,64,298.

Ipca Laboratories Share Price Today reflects a strong upward session, with the stock opening above the previous close, stretching to a fresh 52-week high and still holding a sizeable gain versus the last settlement. The move shows decisive intraday strength, while turnover indicates active participation.

Ipca Laboratories Share Price opened at Rs 1,800.35 against the previous close of Rs 1,733.65, indicating a strong positive start to the session. From there, the stock moved to an intraday high of Rs 1,945.00, which also marked its fresh 52-week high and yearly high. The day’s low was Rs 1,800.35, the same as the opening price, which shows that the stock did not slip below its initial traded level during the period covered by the data.

At the time of the event snapshot, the stock was trading at Rs 1,868.60, still well above the previous close and above the opening level. The absolute gain of Rs 134.95 and percentage rise of 7.78% place the counter among notable Market Movers in the Indian Stock Market session. Current volume stood at 1,64,298 shares, while turnover was Rs 30.70 crore, giving the move enough monetary scale to attract broader attention in Share Market Today coverage.

For readers searching Ipca Laboratories Share News or Ipca Laboratories Share Price Update, the key takeaway is straightforward: the stock delivered a strong gap-up opening, extended to a fresh one-year high and retained substantial gains afterward. With a new 52-week peak now on the board, the next step is to see whether the valuation and profitability data strengthen or challenge this attention.

Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 43,983.43 crore
P/E Ratio	184.72x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Ipca Laboratories Ltd. was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	184.72x
Benchmark Median P/E	21.1x
Benchmark Average P/E	49.38x
Benchmark P/E Range	0x to 1,603.4x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.71%
Company ROCE	-0.26%
Benchmark Median ROCE	13.15%
Company Market Capitalisation	Rs 43,983.43 crore
Benchmark Median Market Cap	Rs 135.27 crore

Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare.

Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ipca Laboratories Ltd. (IPCALAB) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	184.72	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	68.16	6.74	18.65	22.17
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	46.15	1.77	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,612.26	34.27	7.07	-2.6	16.92
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	58.41	8.73	11.42	13.15

Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 43,983.43 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Ipca Laboratories

The stock is being watched because the verified data combines a strong one-day move, a fresh 52-week high and a valuation profile that stands out against both sector benchmarks and listed peers. The result is a clear Stock News event with broader analytical relevance.

• Fresh price event: Ipca Laboratories Share Price rose 7.78% to Rs 1,868.60 and touched a new 52-week high of Rs 1,945.00.
• Strong intraday structure: The stock opened at Rs 1,800.35, never traded below that level in the supplied session data and generated Rs 30.70 crore in turnover.
• Large market size: Market capitalisation of Rs 43,983.43 crore is far above the sector benchmark median and average.
• Valuation contrast: P/E of 184.72 is above the Healthcare benchmark median of 21.10 and average of 49.38, while P/B of 0.45 is below both benchmark levels.
• Profitability watchpoint: ROE of -2.89% and ROCE of -0.26% are below sector medians, adding an important counterpoint to the price strength.

About Ipca Laboratories

Based on the supplied dataset, Ipca Laboratories Ltd. is classified in the Healthcare sector. The article data does not provide a longer company description, business segment split or product-level revenue mix, so the stock is being assessed here primarily through verified market data, valuation ratios, peer comparison and sector benchmarks.

Within the supplied comparison universe, the company is being viewed alongside Healthcare names including pharmaceuticals and healthcare services businesses. What stands out most in this dataset is not an operating segment detail, but the combination of large market capitalisation at Rs 43,983.43 crore and the stock’s fresh 52-week high. For readers following Ipca Laboratories Company News, the current market focus is therefore centred on price action, benchmark valuation gaps and how the company’s return ratios compare with sector and peer figures tracked by Univest.

Track Ipca Laboratories Share Price on Univest

Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors using Univest can track Ipca Laboratories Share Price through live market updates, 52-week levels, market capitalisation, valuation ratios, sector comparisons and peer data in one place. For users following Ipca Laboratories Share Price Live, Univest also helps organise stock analysis around price action, fundamental analysis and broader market context without reducing the story to a single day’s move.

As Ipca Laboratories Share Price News continues to attract attention after this fresh one-year high, readers can use Univest to monitor whether the stock holds above recent breakout zones, how the valuation picture evolves and how it compares with Healthcare peers across the same sector benchmark.

Frequently Asked Questions

What is the latest Ipca Laboratories Share Price Today?

Ans. Ipca Laboratories Share Price Today was Rs 1,868.60 at the time of the supplied snapshot. The stock was up Rs 134.95, or 7.78%, from the previous close of Rs 1,733.65 during the session.

Did Ipca Laboratories hit a fresh 52-week high?

Ans. Yes, the stock touched a fresh 52-week high of Rs 1,945.00 in the current session. That made it a new one-year high, while the traded price later stood at Rs 1,868.60 in the same snapshot.

Why is Ipca Laboratories Share Price rising today?

Ans. The supplied data confirms that Ipca Laboratories Share Price rose 7.78%, opened strongly at Rs 1,800.35 and touched a fresh 52-week high of Rs 1,945.00. However, the verified dataset does not establish a company-specific catalyst.

What was the day range for Ipca Laboratories shares?

Ans. The session range in the supplied data was Rs 1,800.35 to Rs 1,945.00. The opening price and day low were both Rs 1,800.35, showing the stock held above its initial traded level during the period captured.

How much volume and turnover were recorded in Ipca Laboratories?

Ans. The stock recorded current volume of 1,64,298 shares and turnover of Rs 30.70 crore in the supplied market snapshot. Those figures help explain why the move is being tracked closely in today’s stock market coverage.

What is the market capitalisation of Ipca Laboratories?

Ans. Ipca Laboratories had a market capitalisation of Rs 43,983.43 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 135.27 crore and average of Rs 456.49 crore.

Is Ipca Laboratories expensive compared with the Healthcare sector?

Ans. On the supplied P/E data, Ipca Laboratories appears elevated versus the sector benchmark. Its P/E is 184.72, compared with the Healthcare median of 21.10 and average of 49.38 across 201 companies.

How does Ipca Laboratories compare on P/B ratio?

Ans. The company’s P/B ratio is 0.45 in the supplied dataset. That is below the Healthcare sector median of 1.90 and average of 2.30, creating a different signal from the stock’s much higher P/E ratio.

What do the ROE and ROCE figures show for Ipca Laboratories?

Ans. The supplied profitability ratios show ROE at -2.89% and ROCE at -0.26%. Both are below the Healthcare sector medians of 10.71% for ROE and 13.15% for ROCE, respectively. ROE stands at -2.89%.

Where can investors track Ipca Laboratories Share Price and updates?

Ans. Investors can track Ipca Laboratories Share Price on Univest for live price updates, 52-week levels, market capitalisation, valuation ratios, peer comparison and sector context. That helps place daily price action within broader stock analysis.